Your browser is no longer supported. Please, upgrade your browser.
Settings
VTL Vital Therapies, Inc. daily Stock Chart
VTL [NASD]
Vital Therapies, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own0.10% Shs Outstand45.42M Perf Week-31.67%
Market Cap13.31M Forward P/E- EPS next Y-0.91 Insider Trans-99.62% Shs Float38.93M Perf Month-96.53%
Income-54.10M PEG- EPS next Q-0.26 Inst Own32.30% Short Float25.60% Perf Quarter-95.24%
Sales- P/S- EPS this Y-0.10% Inst Trans15.48% Short Ratio3.16 Perf Half Y-95.63%
Book/sh0.62 P/B0.47 EPS next Y-7.70% ROA-101.90% Target Price- Perf Year-93.96%
Cash/sh0.68 P/C0.43 EPS next 5Y15.50% ROE-123.10% 52W Range0.25 - 9.75 Perf YTD-95.08%
Dividend- P/FCF- EPS past 5Y-29.30% ROI- 52W High-96.99% Beta4.16
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin- 52W Low17.20% ATR0.55
Employees97 Current Ratio3.90 Sales Q/Q- Oper. Margin- RSI (14)14.68 Volatility14.51% 21.55%
OptionableYes Debt/Eq0.00 EPS Q/Q-1.80% Profit Margin- Rel Volume0.80 Prev Close0.29
ShortableYes LT Debt/Eq0.00 EarningsAug 07 AMC Payout- Avg Volume3.15M Price0.29
Recom3.00 SMA20-93.34% SMA50-95.73% SMA200-95.20% Volume2,506,125 Change-0.34%
Sep-12-18Downgrade William Blair Outperform → Mkt Perform
Sep-12-18Downgrade Raymond James Outperform → Mkt Perform
Sep-12-18Downgrade Cantor Fitzgerald Overweight → Neutral
May-19-17Initiated Raymond James Outperform $6
Mar-09-16Reiterated Canaccord Genuity Buy $8 → $10
Sep-29-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
Aug-24-15Reiterated Canaccord Genuity Buy $35 → $8
Aug-24-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
Aug-24-15Downgrade Credit Suisse Outperform → Neutral $9
Aug-15-14Reiterated Canaccord Genuity Buy $20 → $35
May-12-14Initiated Canaccord Genuity Buy $20
Sep-20-18 03:04PM  Who Are Vital Therapies Incs (NASDAQ:VTL) Major Shareholders? Simply Wall St.
Sep-14-18 08:36AM  Is the Options Market Predicting a Spike in Vital Therapies (VTL) Stock? Zacks -29.75%
Sep-13-18 08:00AM  Todays Research Reports on Stocks to Watch: Bausch Health Companies and Vital Therapies ACCESSWIRE +10.71%
Sep-12-18 06:46AM  Vital Therapies shares slide 86% after biotech says it will scrap treatment for liver failure MarketWatch -92.86%
05:00AM  Vital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in Survival GlobeNewswire
Sep-08-18 07:22AM  3 Biotech Stocks That Could Double Your Money Motley Fool
Aug-14-18 08:35AM  Is the Options Market Predicting a Spike in Vital Therapies (VTL) Stock? Zacks
Aug-07-18 05:03PM  Vital Therapies: 2Q Earnings Snapshot Associated Press
04:01PM  Vital Therapies Announces Second Quarter 2018 Financial Results GlobeNewswire
Aug-06-18 12:05PM  William Blair Upgrades Vital Therapies Ahead Of September Liver Failure Data Benzinga +8.64%
Jul-31-18 04:01PM  Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast GlobeNewswire
Jun-26-18 08:35AM  Are Options Traders Betting on a Big Move in Vital Therapies (VTL) Stock? Zacks
Jun-25-18 08:00AM  Vital Therapies Joins the Russell 3000 Index® GlobeNewswire
Jun-12-18 04:30PM  Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jun-07-18 08:00AM  Vital Therapies to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire -8.41%
Jun-06-18 03:34AM  How Does Investing In Vistal Gdynia SA. (WSE:VTL) Impact Your Portfolio? Simply Wall St. +10.31%
May-24-18 08:01AM  Vital Therapies Hosting Analyst R&D Day Today GlobeNewswire
May-11-18 08:01AM  Vital Therapies to Host Analyst R&D Day on May 24, 2018 GlobeNewswire
May-10-18 09:36AM  Edited Transcript of VTL earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-08-18 05:16PM  Vital Therapies: 1Q Earnings Snapshot Associated Press
04:01PM  Vital Therapies Announces First Quarter 2018 Financial Results GlobeNewswire
May-07-18 08:15AM  What Does Vistal Gdynia SA.s (WSE:VTL) Ownership Structure Look Like? Simply Wall St.
Apr-26-18 04:05PM  Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast GlobeNewswire
Apr-25-18 04:30PM  Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
01:02PM  Are Vistal Gdynia SA.s (WSE:VTL) Interest Costs Too High? Simply Wall St.
Apr-12-18 07:43AM  Will Vital Therapies Incs (NASDAQ:VTL) Earnings Grow In The Next Couple Of Years? Simply Wall St.
Mar-30-18 02:31PM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Mar-22-18 08:01AM  Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects GlobeNewswire
Mar-20-18 08:42AM  Options Traders Expect Huge Moves in Vital Therapies (VTL) Stock Zacks
Mar-16-18 03:46PM  Edited Transcript of VTL earnings conference call or presentation 13-Mar-18 8:30pm GMT Thomson Reuters StreetEvents +8.18%
Mar-13-18 04:15PM  Vital Therapies reports 4Q loss Associated Press
04:01PM  Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
12:00PM  Vital Therapies, Inc. to Host Earnings Call ACCESSWIRE
Mar-12-18 09:15PM  When Will Vital Therapies Inc (NASDAQ:VTL) Breakeven? Simply Wall St.
Feb-27-18 07:59AM  Vital Therapies Announces Upcoming Fourth Quarter and Full Year Financial Results Conference Call with Webcast and Participation in Upcoming Conference GlobeNewswire
Jan-05-18 08:01AM  Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Dec-11-17 08:00AM  Vital Therapies Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-04-17 04:29PM  Vital Therapies Appoints Russell J. Cox as Chief Executive Officer and Board Member Effective January 3, 2018 GlobeNewswire
Nov-08-17 08:01AM  Vital Therapies to Webcast Presentation at Upcoming Investor Conference GlobeNewswire
Oct-31-17 03:50PM  Edited Transcript of VTL earnings conference call or presentation 25-Oct-17 8:30pm GMT Thomson Reuters StreetEvents
Oct-25-17 05:56PM  Vital Therapies reports 3Q loss Associated Press
04:01PM  Vital Therapies Announces Third Quarter 2017 Financial Results GlobeNewswire
07:50AM  VITAL THERAPIES INC to Host Earnings Call ACCESSWIRE
Oct-18-17 08:01AM  Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast GlobeNewswire
Oct-03-17 01:06PM  All You Need To Know About Vital Therapies Incs (VTL) Risks Simply Wall St. +5.45%
Sep-15-17 06:31PM  Is It Too Late To Buy Vital Therapies Inc (VTL)? Simply Wall St. +5.88%
Sep-11-17 08:01AM  Vital Therapies Announces Recent and Upcoming Scientific Presentations and Participation in Upcoming Investor Conference GlobeNewswire
Sep-06-17 08:01AM  Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors GlobeNewswire
Aug-07-17 08:17PM  Edited Transcript of VTL earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-03-17 04:01PM  Vital Therapies Announces Second Quarter 2017 Financial Results GlobeNewswire +13.46%
Jul-26-17 04:01PM  Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast GlobeNewswire
Jun-05-17 08:01AM  Vital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis GlobeNewswire
May-12-17 01:51PM  Edited Transcript of VTL earnings conference call or presentation 10-May-17 8:30pm GMT Thomson Reuters StreetEvents -11.43%
May-11-17 09:52PM  Edited Transcript of VTL earnings conference call or presentation 10-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-10-17 10:15AM  Investor Network: VITAL THERAPIES INC to Host Earnings Call Accesswire
May-09-17 07:16PM  Vital Therapies reports 1Q loss Associated Press
04:01PM  Vital Therapies Announces First Quarter 2017 Financial Results GlobeNewswire
May-02-17 04:01PM  Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call With Webcast GlobeNewswire
Mar-29-17 04:09PM  VITAL THERAPIES INC Files SEC form 8-K, Other Events
04:01PM  Vital Therapies Announces Exercise in Full of Underwriters Option to Purchase Additional Shares of Common Stock in Public Offering GlobeNewswire
Mar-23-17 04:20PM  VITAL THERAPIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
Mar-22-17 09:07AM  Vital Therapies Announces Pricing of Public Offering of Common Stock GlobeNewswire -8.24%
Mar-21-17 04:14PM  VITAL THERAPIES INC Files SEC form 8-K, Other Events -6.59%
04:01PM  Vital Therapies Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-11-17 01:04PM  VITAL THERAPIES INC Financials
Mar-08-17 02:56PM  Edited Transcript of VTL earnings conference call or presentation 7-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
Mar-07-17 04:14PM  Vital Therapies reports 4Q loss Associated Press
04:11PM  VITAL THERAPIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
04:01PM  Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Vital Therapies Inc Earnings Release - After Market Close
Feb-27-17 04:01PM  Vital Therapies Announces Upcoming Fourth Quarter and Full Year 2016 Financial Results Conference Call With Webcast GlobeNewswire
Jan-09-17 08:00AM  Vital Therapies Provides Corporate Update GlobeNewswire
Dec-15-16 10:33AM  Vital Therapies, Inc. :VTL-US: Earnings Analysis: Q3, 2016 By the Numbers : December 15, 2016 Capital Cube -6.45%
10:33AM  Vital Therapies, Inc. :VTL-US: Earnings Analysis: Q3, 2016 By the Numbers : December 15, 2016
Nov-06-16 10:19PM  Edited Transcript of VTL earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-03-16 05:55PM  Vital Therapies reports 3Q loss
04:05PM  VITAL THERAPIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
04:01PM  Vital Therapies Announces Third Quarter Financial Results GlobeNewswire
07:07AM  Q3 2016 Vital Therapies Inc Earnings Release - After Market Close
Nov-01-16 01:16PM  Invesco Closed-End Funds Declare Dividends PR Newswire
Oct-25-16 04:01PM  Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast GlobeNewswire -5.04%
Oct-11-16 02:37PM  Vital Therapies, Inc. :VTL-US: Earnings Analysis: Q2, 2016 By the Numbers : October 11, 2016
Sep-28-16 07:02AM  7 Stocks Under $10 That Could Make You a Lot of Money
Sep-13-16 04:01PM  Vital Therapies Provides Corporate Update GlobeNewswire
Aug-29-16 04:20PM  VITAL THERAPIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Aug-16-16 12:16PM  Heavy Insider Selling at Prologis Inc. (PLD) and PRA Health Sciences Inc. (PRAH), Plus Insider Buying at 3 Other Companies at Insider Monkey
Aug-15-16 08:40AM  VITAL THERAPIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:01AM  Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors GlobeNewswire
Aug-03-16 07:19AM  Edited Transcript of VTL earnings conference call or presentation 2-Aug-16 8:30pm GMT
Aug-02-16 05:43PM  Vital Therapies reports 2Q loss
04:09PM  VITAL THERAPIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
04:01PM  Vital Therapies Announces Second Quarter Financial Results GlobeNewswire
07:07AM  Q2 2016 Vital Therapies Inc Earnings Release - After Market Close
Jul-21-16 04:01PM  Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast GlobeNewswire
Jun-14-16 09:44AM  Looking for a Growth Stock? Why It is Time to Focus on Vital Therapies (VTL)
Jun-02-16 01:05PM  Vital Therapies, Inc. :VTL-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016
May-27-16 04:33PM  VITAL THERAPIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
May-23-16 08:01AM  Vital Therapies Enrolls First Subject in VTL-308 GlobeNewswire
May-18-16 04:08PM  VITAL THERAPIES INC Files SEC form 8-K, Change in Directors or Principal Officers
May-12-16 05:03PM  Edited Transcript of VTL earnings conference call or presentation 10-May-16 8:30pm GMT
Vital Therapies, Inc., a biotherapeutic company, focuses on developing and commercializing a cell-based therapy for the treatment of acute forms of liver failure in the United States. Its product candidate is the ELAD system, an extracorporeal human allogeneic cellular liver therapy that is in Phase III clinical trials helps in enhancing the rates of survival in patients with acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Halperin Errol R.DirectorSep 25Sale0.2910,0002,9000Sep 25 07:28 PM
Halperin Errol R.DirectorSep 25Sale0.2989,41725,9400Sep 25 07:28 PM
BIENAIME JEAN JACQUESDirectorSep 24Sale0.3026,6198,00218,500Sep 24 07:24 PM
Godshall Douglas EvanDirectorSep 19Sale0.3569,37524,1910Sep 21 04:19 PM
Satter Muneer ADirectorSep 17Sale0.297,044,7772,054,2570Sep 17 09:30 PM
Satter Muneer ADirectorSep 14Sale0.36447,500160,3847,044,777Sep 17 09:30 PM
Satter Muneer ADirectorSep 13Sale0.503,890,0001,930,9967,492,277Sep 17 09:30 PM
Hasnain FaheemDirectorSep 13Sale0.44177,44377,6794,500Sep 17 09:26 PM
BIENAIME JEAN JACQUESDirectorSep 13Sale0.4720,0009,40045,119Sep 17 09:24 PM
Cohen CherylDirectorSep 12Sale0.553,5001,9250Sep 14 04:08 PM
Satter Muneer ADirectorDec 13Buy5.5750,000278,57011,382,277Dec 14 06:47 PM
Satter Muneer ADirectorDec 12Buy5.4050,000269,76511,332,277Dec 14 06:47 PM
Satter Muneer ADirectorDec 11Buy4.9650,000248,22511,282,277Dec 11 05:35 PM
Satter Muneer ADirectorDec 08Buy4.9250,000246,18511,232,277Dec 11 05:35 PM
Satter Muneer ADirectorDec 07Buy4.7750,000238,73011,182,277Dec 11 05:35 PM